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and nondiabetics. Longitudinal mixed model analyses accounted for multiple catheteriza- 
tions and multiple grafts per patient. 
Results: Slightly fewer in situinternal thoraclc attely (ITA, n=2,394) and saphenous vein 
grafts (SVG, n=l0,018) were patent across time in diabetics than in nondiabetics 
(P=.OO6; Figure). Risk-adjusted patency declined progressively for both types of conduit 
(Pc.OOl), but the decline was more rapid for SVGs (Pc.001). 
Conclusion: Unlike percutaneous coronary interventions, coronary awry bypass graft 
patency is similar in diabetics and nondiabetics. Therefore, coronary artery bypass SUP 
gery should be as durable in diabetics as nondiabetics. 
(EF) was 22.7 %. The mean number of grafts was 2.5 per patient. Myoblast Cells were 
delivered successfully in all subjects without any injection-related complications. Purity of 
the cells ranged from 47% lo 98% CD56+ myoblasts. Nine months follow-up revealed no 
significant adverse events associated with either cell transplantation or the injection pro- 
cedure. One patient had non-sustained ventricular tachycardia. Echocardiography, PET 
and MRI scans showed evidence of viability in the area df grafted scar. The mean EF 
improved from 22.7% to 35.9%. 
Conclusion: These preliminary data suggest that autologous myoblast cell transplanta- 
tion. within an infarcted myocardium during CABG. was feasible and safe. Improvement 
in viability and wall thickness is encouraging. Future cllnical trials evaluating the effect of 
autologous myoblast cell transplantation on left ventricular function are warranled. Final 
results on 12 patients will be presented. 
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84BFO-6 Combined Angioplasty and Robotic Coronary Bypass 
Surgery in Multivessel Coronary Artery Disease 
Kenneth D. Stahl, Kenneth R. Fromkin, And@ Bochenek, Douglas W. Boyd, Thomas A. 
Vassiliades, Hratch L. Karamanoukian, Marek Cisowski, Cleveland Clinic Florida, 
Weston, FL 
Background: Long-term benefits of a left internal mammary artery graft (LIMA) to the left 
anterior descending coronary arlery (LAD) are well known. This can now be accom- 
plished with minimally invasive robotic surgery without stemotomy or cardiopulmonary 
bypass. A four institution trial of a hybrid revascularizatu- strategy involving minimally 
invasive surgery for LIMA graft to the LAD and percutaneous coronary intewantion (PCI) 
to non-LAD vessels is reporied for multivessel disease. 
Methods: 150 patients ware treated with robotic endoscoplc LIMA grafts to the LAD and 
PCI to non-LAD vessels. All surgery was carried out using the Aesop or Zeus intra-oper- 
ative robotic devices. No patient recewed a stern&my incision or was placed on car- 
diopulmonary bypass. PCI was performed on non-LAD vessels before or after surgery. 
Results: 317 vessels were treated in 150 patients (2.1 vessels/patient). There were no 
early or late mortalities. Based on “Intention to tread all patlents were deemed totally 
revascularlzed in this hybrid manner. Complications included two intra-operative myocar- 
dial infarctions during surgaly (1.5%) and 1 (0.73%) stroke during PCI. Follow-up was 
complete in 1361150 (90.1%) patients at a mean post-procedure time of 12.1 (0.5 - 35) 
months. Post-procedure angina class was 1 .I (1 - 2). 79 (52.3%) patients had follow-up 
angiogram at 13.1 (0.3 35) months, 100% of LIMA grafts were patent. 77/79 (97.5%) 
were Fitzgibbon ‘A’, 2i79 (2.5%) Fltzgibbon ‘8’. 12/79 (15.2%) PCI vessels showed 
angiographic restenosis and 3/79 (3.8%) were occluded. 10 (7.3%) patients underwent 
repeat PCI, none had repeat surgery. 
Conclusion: A hybrid revascularization strategy of atraumatic robotic LIMA grafting lo the 
LAD combined with PCI of non-LAD vessels can be carried out with minimal complica- 
tions. outstanding 1 year LAD patency rates, and excellent symptom relief in patients 
with multivessel coronary artery disease. This hybrid procedure combines the best of 
surgical and catheter based therapy in a minimally invasive manner. 
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848FO-4 Cardiac Outcome and Cost-Effectiveness One Year 
After Off-Pump and On-Pump Coronary Artery Bypass 
Surgery: Results From a Randomized Study 
Hendrik M. Nathoe. Diederik van Dljk. Erik W. Jansen, Willem J. Suyker, Jan C. 
Diephuis, Wim Jan van Boven, Aarl Brute! de la Riviera Cornelius Borst, Cor J. 
Kalkman, Diederick E. Grobbee, Erik Buskens, Peter P. de Jaegere, The OCTOPUS 
Study Group, University Medical Center Utrecht, Utrecht, The Netherlands. Isala Clinics, 
Zwolle. The Netherlands 
Background: Avoiding cardiopulmonary bypass during coronary artery bypass surgety 
may reduce perioperative morbidity and costs. It is, however, unknown whether cardiac 
outcome is similar to bypass surgery using cardiopulmonary bypass. The purpose of this 
study was to compare cardiac outcome and cost-effectiveness at one year between 
bypass surgery on the beating heart (off-pump surgery) and conventional bypass surgery 
with the use of cardiopulmonary bypass (on-pump surgery). 
Methods: In a multicenter randomized clinical trial, 142 patients were randomly assigned 
to off-pump surgery and 139 patients to on-pump surgely. Cardiac outcome, cost-effec- 
tiveness and grafl patency ware determined at one year after surgery. The uncertainty 
surrounding the cost-effectiveness analysis was addressed by standard bootstrap tech- 
niques. 
Results: At one year, survival free from stroke, myocardial infarction and coronary rs- 
intervention was 88.0% after off-pump and 90.6% after on-pump surgery (p=O.48). Sur- 
vival free from angina was 89.3% versus 89.0% (p=O.93), respectively. Grafl patency 
determined in a randomized subset of patients, was 91% in the off-pump and 93% in the 
on-pump group (p=O.65). Off-pump surgery reduced costs by $2329 (13.1%) per patient 
($15479 versus $17808; pcO.01). Quality adjusted lifetime after off-pump and on-pump 
surgery was 0.82 versus 0.83 year (p=O.70). The cost-effectiveness ratio for off-pump 
compared with on-pump surgery as estimated by bootstrapping, remained in 98% of esti- 
mates below the conservative ‘willingness to pay’ threshold of $20,000 per quality 
adjusted life year. 
Conclusions: At one year, off-pump surgery was more cost-effective than on-pump sw 
gery. while maintaining comparable cardiac outcome. In selected patients, off-pump sur- 
gary as an alternative for on-pump surgery is justified from an economic perspective. 
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84BFO-5 Safety and Feasibility of Autologous Myoblast 
Size as Measured by Gadolinium-DTPA Late 
Transplantation in Patients Undergoing Coronary 
Enhancement Magnetic Resonance Imaging 
Artery Bypass Grafting: Results From the United States Thomas N. Martin, Bjoern A. Groenning, Tracey Steedman, John E. Foster, Alex T. 
Experience Elliott, Henry J. Dargv?, Glasgow Cardiac Magnetic Resonance Unit, Glasgow, United 
Kinodom 
Nabil Dib Patnck McCarthy. Ann Campbell, Johnathan Dinsmore, Michael Yeager, W. R -1 
MacLellan. Grew Fonarow. Robert E. Michler. Diane Buchele. Marwan Ghazoul. 
Edward B..Diath&h, Arizona Heart Institute, Phoenix, AZ 
Background: Autologous myoblast cell transplantation to repair myocardial infarction 
has been shown to be safe and effective in preclinical studies. The objective of this study 
was to demonstrate the feasibility and safety of myoblast transplantation in humans. 
Methods: Patients scheduled to undergo elective coronary artery bypass grafting 
(CABG) ware enrolled in the US multicenter clinical trial over a one-year period. Subjects 
with previous myocardial infarction and a I& ventricular ejection fraction < 30% were eli- 
gible to participate. A skeletal muscle biopsy of approximately 2 to 5 grams was excised 
from each patient with subsequent isolation and expansion of myoblast cells over a 
period of 2-3 weeks. Between 3 and 30 direct injections of myoblasts were delivered into 
the area of infarction at the time of surgery using one of 4 escalating cell doses ranging 
from 10 million cells lo 300 million cells. Pre and post-injection ECG, echocardlogram, 
Halter monitoring, positron emission tomography (PET) and magnetic resonance imag- 
ing (MRI) were performed. 
Results: Eleven patients underwent autologous myoblast cell transplantation combined 
with CABG. The mean age of patients was 57 years. The mean baseline ejection fraction 
Background. The purpose of the study was to assess the relationship between the sin- 
gle measure of cardiac troponin I (Tnl) used in clinical practice (8 to 12 hours after onset 
of chest pain) and infarct size and left ventricular (LV) dimensions and systolic function 
as measured by magnetic resonance imaging (MR). 
Methods. 13 male and 6 female (mean (range) age=60 (37-83) years) incident hospital 
admisslons with acute coronary syndromes were consecutively recruited. 9119 (47%) 
were treated with primaly thrombolysis. Blood sampling for Tnl took place E-12 hours 
after onset of chest pain and samples for cratine kinase (CK) and CKMB were collected 
at admission, after 12 hours and at the MR scan. MR was performed at a median (range) 
of 69 (16-120) hours from onset of chest pain on a Siemens Sonata 1.5T system using a 
phased array chest coil. LV dimensions were evaluated by cinematographic (TrueFISP) 
breath-hold sequence. Late contrast enhanced (LE) MR was performed 15 minutes after 
peripheral injection of 0.2 mmollkg gadolinium-DTPA using a breath-hold segmented tur- 
boFLASH sequence with non-seledive inversion-recovery. Images were evaluated by 2 
independent and blinded observers. 
Results. Tnl (median (range) 24 (0.3-117) pg/ml) strongly correlated with LE volume 
(mean (SD) 13 (15) ml): r=O.El, p<O.OOOl and with LV ejection fraction (mean (SD) 59 
(9.7)%): r=-0.58. p=O.O009. Tnl was unrelated lo LV end-diaslollc (140 (36) ml) and end- 
